2 assets in Adenomatous Colon Polyp

Therapeutic assets addressing Adenomatous Colon Polyp, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Aspirin Adenomatous Colon Polyp	University of Calgary	P2	CCC (53)
Dordaviprone Adenomatous Colon Polyp	National Cancer Institute (NCI)	P1	C (39)